| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7df267c0e21d6b0ad2a3490807c38477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4cba9ad3fb058b4d771733c6a48351f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-92 |
| filingDate |
2018-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ba0ff11d1ce4ad4e89deade8182580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb41d53de44dd48e4e044d0b5c1857c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3ea934466fe763fac16f5f09d9a347b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0c877325e897b8bc4699f3be0e949c |
| publicationDate |
2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018265489-A1 |
| titleOfInvention |
Novel anticancer agent |
| abstract |
[wherein each symbol is as described in the DESCRIPTION] or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267797-B2 |
| priorityDate |
2014-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |